NATURE’S SUNSHINE PRODUCTS, INC. Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net of -$233.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-08.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet · last filed 2019-03-08
- NATURE’S SUNSHINE PRODUCTS, INC. adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2016 was -$233.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2015 was -$520.00K, a 269.38% decline from fiscal 2014.
- NATURE’S SUNSHINE PRODUCTS, INC. adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2014 was $307.00K.
| Period end | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 12 month |
|---|---|
| 2016-12-31 | -$233.00K 10-K · filed 2019-03-08 |
| 2015-12-31 | -$520.00K 10-K · filed 2018-03-16 |
| 2014-12-31 | $307.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |